Cargando…

Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model

Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Funuyet-Salas, Jesús, Martín-Rodríguez, Agustín, Pérez-San-Gregorio, María Ángeles, Romero-Gómez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161151/
https://www.ncbi.nlm.nih.gov/pubmed/34065216
http://dx.doi.org/10.3390/jcm10102208
_version_ 1783700442832699392
author Funuyet-Salas, Jesús
Martín-Rodríguez, Agustín
Pérez-San-Gregorio, María Ángeles
Romero-Gómez, Manuel
author_facet Funuyet-Salas, Jesús
Martín-Rodríguez, Agustín
Pérez-San-Gregorio, María Ángeles
Romero-Gómez, Manuel
author_sort Funuyet-Salas, Jesús
collection PubMed
description Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined whether self-efficacy exerted a moderating role in these associations. QoL (SF-12), social support (MSPSS), depressive symptoms (HADS), self-efficacy (GSE), physical activity (IPAQ) and diet (MEDAS) were evaluated in 413 biopsy-proven NAFLD patients. Mediation and moderated mediation models were conducted using the SPSS PROCESS v3.5 macro. Results showed that depressive symptoms mediated the relationship between physical QoL and adherence to physical activity (indirect effect = 6.248, CI = 1.917–10.727), as well as the relationship between social support and adherence to diet (indirect effect = 0.148, CI = 0.035–0.275). Self-efficacy also moderated the indirect effects of QoL and social support on therapeutic adherence through depressive symptoms. Specifically, the higher self-efficacy was, the lower the negative impact on the NAFLD patient’s mental health. In conclusion, self-efficacy is defined as a protective factor for therapeutic adherence by NAFLD patients with a psychosocial risk profile. Self-efficacy should, therefore, be a main psychological target in future multidisciplinary NAFLD approaches.
format Online
Article
Text
id pubmed-8161151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81611512021-05-29 Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model Funuyet-Salas, Jesús Martín-Rodríguez, Agustín Pérez-San-Gregorio, María Ángeles Romero-Gómez, Manuel J Clin Med Article Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined whether self-efficacy exerted a moderating role in these associations. QoL (SF-12), social support (MSPSS), depressive symptoms (HADS), self-efficacy (GSE), physical activity (IPAQ) and diet (MEDAS) were evaluated in 413 biopsy-proven NAFLD patients. Mediation and moderated mediation models were conducted using the SPSS PROCESS v3.5 macro. Results showed that depressive symptoms mediated the relationship between physical QoL and adherence to physical activity (indirect effect = 6.248, CI = 1.917–10.727), as well as the relationship between social support and adherence to diet (indirect effect = 0.148, CI = 0.035–0.275). Self-efficacy also moderated the indirect effects of QoL and social support on therapeutic adherence through depressive symptoms. Specifically, the higher self-efficacy was, the lower the negative impact on the NAFLD patient’s mental health. In conclusion, self-efficacy is defined as a protective factor for therapeutic adherence by NAFLD patients with a psychosocial risk profile. Self-efficacy should, therefore, be a main psychological target in future multidisciplinary NAFLD approaches. MDPI 2021-05-20 /pmc/articles/PMC8161151/ /pubmed/34065216 http://dx.doi.org/10.3390/jcm10102208 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Funuyet-Salas, Jesús
Martín-Rodríguez, Agustín
Pérez-San-Gregorio, María Ángeles
Romero-Gómez, Manuel
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title_full Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title_fullStr Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title_full_unstemmed Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title_short Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
title_sort influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: a moderated mediation model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161151/
https://www.ncbi.nlm.nih.gov/pubmed/34065216
http://dx.doi.org/10.3390/jcm10102208
work_keys_str_mv AT funuyetsalasjesus influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel
AT martinrodriguezagustin influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel
AT perezsangregoriomariaangeles influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel
AT romerogomezmanuel influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel